Gene · 4284
Papers2,928
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 2,928
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Evaluation of the relationship between incisor torque and profile aesthetics in patients having orthodontic extractions compared to non-extractions. | Clin Oral Investig | 2023 | 37500932 | PubTator, text mining | PubMed |
| The kynurenine pathway of tryptophan metabolism: a neglected therapeutic target of COVID-19 pathophysiology and immunotherapy. | Biosci Rep | 2023 | 37486805 | PubTator, text mining | PubMed |
| Methods for sampling wound fluid from venous leg ulcers for molecular analyses: A scoping review. | Int Wound J | 2023 | 37455090 | PubTator, text mining | PubMed |
| Mesenchymal stem cells in lung diseases and their potential use in COVID-19 ARDS: A systematized review. | Clinics (Sao Paulo) | 2023 | 37454534 | PubTator, text mining | PubMed |
| Cytokines as Biomarkers for Evaluating Physical Exercise in Trained and Non-Trained Individuals: A Narrative Review. | Int J Mol Sci | 2023 | 37446334 | PubTator, text mining | PubMed |
| The Role of Aquaporins in Spinal Cord Injury. | Cells | 2023 | 37443735 | PubTator, text mining | PubMed |
| Macrophages drive KSHV B cell latency. | Cell Rep | 2023 | 37440412 | PubTator, text mining | PubMed |
| Cerulean cataract. | Pan Afr Med J | 2023 | 37426466 | PubTator, text mining | PubMed |
| Biomarkers of particulate matter exposure in patients with chronic obstructive pulmonary disease: a systematic review. | J Thorac Dis | 2023 | 37426121 | PubTator, text mining | PubMed |
| ErbBs in Lens Cell Fibrosis and Secondary Cataract. | Invest Ophthalmol Vis Sci | 2023 | 37418274 | PubTator, text mining | PubMed |
Association of High-Dose Erythropoietin With Circulating Biomarkers and Neurodevelopmental Outcomes Among Neonates With Hypoxic Ischemic Encephalopathy: A Secondary Analysis of the HEAL Randomized Clinical Trial. | JAMA Netw Open | 2023 | 37418263 | PubTator, text mining | PubMed |
| Double Plasma Molecular Adsorption System with Sequential Low-dose Plasma Exchange in Patients with Hepatitis B Virus-related Acute-on-chronic Liver Failure: A Prospective Study. | J Clin Transl Hepatol | 2023 | 37408804 | PubTator, text mining | PubMed |
| One-step synthesis of chiral molecularly imprinted polymer TiO2 nanoparticles for enantioseparation of phenylalanine in coated capillary electrochromatography. | Mikrochim Acta | 2023 | 37391671 | PubTator, text mining | PubMed |
| Tanshinone IIA changed the amniotic fluid volume and regulated expression of AQP1 and AQP3 in amniotic epithelium cells: a promising drug treating abnormal amniotic fluid volume. | Mol Med | 2023 | 37386378 | PubTator, text mining | PubMed |
| Immune profiling in multiple sclerosis: a single-center study of 65 cytokines, chemokines, and related molecules in cerebrospinal fluid and serum. | Front Immunol | 2023 | 37383229 | PubTator, text mining | PubMed |
| Lens regeneration in situ using hESCs-derived cells -similar to natural lens. | iScience | 2023 | 37378332 | PubTator, text mining | PubMed |
| Chemokine Analysis in Patients with Metastatic Uveal Melanoma Suggests a Role for CCL21 Signaling in Combined Epigenetic Therapy and Checkpoint Immunotherapy. | Cancer Res Commun | 2023 | 37377898 | PubTator, text mining | PubMed |
| Urine-Derived Renal Epithelial Cells (URECs) from Transplanted Kidneys as a Promising Immunomodulatory Cell Population. | Cells | 2023 | 37371100 | PubTator, text mining | PubMed |
| Independent Membrane Binding Properties of the Caspase Generated Fragments of the Beaded Filament Structural Protein 1 (BFSP1) Involves an Amphipathic Helix. | Cells | 2023 | 37371051 | PubTator, text mining | PubMed |
| Direct Differentiation of Bone Marrow Mononucleated Cells Into Insulin-Producing Cells Using 4 Specific Soluble Factors. | Stem Cells Transl Med | 2023 | 37350544 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4284/papers?page=11